Fesarius Therapeutics Email Format
Biotechnology ResearchNew York, United States11-50 Employees
Fesarius Therapeutics is a New York, NY-based biotechnology company focused on regenerative medicine. It develops tissue-engineered products intended for reconstructive and aesthetic surgery, with a focus on improving wound healing and dermal restoration. The company’s lead product, DermiSphere, is a dermal regeneration template designed to manage wounds, grounded in technology from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine. The organization targets clinicians involved in dermal repair and wound management within the broader biotechnology research sector. DermiSphere aims to rapidly reconstruct the dermis after full-thickness skin loss, addressing a key clinical need in wound care. The company is described as a relatively small enterprise based in New York, NY.